New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
The company posted revenue of Rs. 703 crore in Q4 FY26
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Wadhwa brings over two decades of experience driving growth, transformation, and customer-centric strategies in the medical devices and diagnostics sector
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Tamir brings more than 20 years of experience in the medical technology sector
Subscribe To Our Newsletter & Stay Updated
